These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9323627)

  • 1. The effect of 12 months' treatment with eicosapentaenoic acid in five children with cystic fibrosis.
    Thies NH
    J Paediatr Child Health; 1997 Aug; 33(4):349-51. PubMed ID: 9323627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4.
    Lawrence R; Sorrell T
    Lancet; 1993 Aug; 342(8869):465-9. PubMed ID: 8102430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.
    Hanssens L; Thiébaut I; Lefèvre N; Malfroot A; Knoop C; Duchateau J; Casimir G
    Prostaglandins Leukot Essent Fatty Acids; 2016 May; 108():45-50. PubMed ID: 27154364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
    Olveira G; Olveira C; Acosta E; Espíldora F; Garrido-Sánchez L; García-Escobar E; Rojo-Martínez G; Gonzalo M; Soriguer F
    Arch Bronconeumol; 2010 Feb; 46(2):70-7. PubMed ID: 20045240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
    De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
    JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
    Ros M; Casciaro R; Lucca F; Troiani P; Salonini E; Favilli F; Quattrucci S; Sher D; Assael BM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious Diseases Pharmacotherapy for Children With Cystic Fibrosis.
    Molloy L; Nichols K
    J Pediatr Health Care; 2015; 29(6):565-78; quiz 579-80. PubMed ID: 26498903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis papers of the year 2012.
    Doull I
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():28-30. PubMed ID: 23452761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.
    Henderson WR; Astley SJ; McCready MM; Kushmerick P; Casey S; Becker JW; Ramsey BW
    J Pediatr; 1994 Mar; 124(3):400-8. PubMed ID: 8120709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
    Teper A; Jaques A; Charlton B
    J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of lumacaftor/ivacaftor to treat acute deterioration in paediatric cystic fibrosis.
    Hammond JA; Connett GJ
    Paediatr Respir Rev; 2018 Jun; 27():16-17. PubMed ID: 29914743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.
    Borowitz D; Lubarsky B; Wilschanski M; Munck A; Gelfond D; Bodewes F; Schwarzenberg SJ
    Dig Dis Sci; 2016 Jan; 61(1):198-207. PubMed ID: 26250833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C; Tamalet A; Thien HV; Taytard J; Perisson C; Nathan N; Clement A; Boelle PY; Corvol H
    Respir Med; 2016 Aug; 117():1-6. PubMed ID: 27492507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis.
    Gustafsson PM; Aurora P; Lindblad A
    Eur Respir J; 2003 Dec; 22(6):972-9. PubMed ID: 14680088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
    JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases.
    Njoroge SW; Laposata M; Boyd KL; Seegmiller AC
    J Nutr Biochem; 2015 Jan; 26(1):36-43. PubMed ID: 25448610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
    Accurso FJ; Moss RB; Wilmott RW; Anbar RD; Schaberg AE; Durham TA; Ramsey BW;
    Am J Respir Crit Care Med; 2011 Mar; 183(5):627-34. PubMed ID: 21169471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.